Actinogen Medical (ACW) 2023年年度报告「ASX」.pdf

《Actinogen Medical (ACW) 2023年年度报告「ASX」.pdf》由会员分享，可在线阅读，更多相关《Actinogen Medical (ACW) 2023年年度报告「ASX」.pdf（74页珍藏版）》请在三个皮匠报告上搜索。

1、Annual Report 2023ContentsContentsWho we are 1Highlights 2The Xanamem Pipeline 3How Xanamem Targets Non-amyloid Disease Mechanisms via Cortisol in Alzheimers Disease 4Clinical Trials Program Overview 5Chairs Letter 6Chief Executive Officers Letter 8Vision and Strategy 10Operating&Financial Review 12

2、Board of Directors 18Executive Leadership Team 20Directors Report 22Remuneration Report(Audited)24Auditors Independence Declaration 37Financial Report 38Notes to the Financial Statements 43Directors Declaration 63Independent Auditors Report 64Shareholder Information 68 Corporate Directory 70Disclaim

3、erThis Annual Report may contain certain forward-looking statements that are not historical facts;are based on subjective estimates,assumptions and qualifications;and relate to circumstances and events that have not taken place and may not take place.Such forward looking statements should be conside

4、red“at-risk statements”-not to be relied upon as they are subject to known and unknown risks,uncertainties and other factors(such as significant business,economic and competitive uncertainties/contingencies and regulatory and clinical development risks,future outcomes and uncertainties)that may lead

5、 to actual results being materially different from any forward looking statement or the performance expressed or implied by such forward looking statements.You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.Actinogen Medical does n

6、ot undertake any obligation to revise such statements to reflect events or any change in circumstances arising after the date hereof,or to reflect the occurrence of or non-occurrence of any future events.Past performance is not a reliable indicator of future performance.Actinogen Medical does not ma